Literature DB >> 25933732

Effect of Smaller Left Ventricular Capture Threshold Safety Margins to Improve Device Longevity in Recipients of Cardiac Resynchronization-Defibrillation Therapy.

Daniel A Steinhaus1, Jonathan W Waks1, Robert Collins2, Karen Kleckner2, Daniel B Kramer1, Peter J Zimetbaum3.   

Abstract

Device longevity in cardiac resynchronization therapy (CRT) is affected by the pacing capture threshold (PCT) and programmed pacing amplitude of the left ventricular (LV) pacing lead. The aims of this study were to evaluate the stability of LV pacing thresholds in a nationwide sample of CRT defibrillator recipients and to determine potential longevity improvements associated with a decrease in the LV safety margin while maintaining effective delivery of CRT. CRT defibrillator patients in the Medtronic CareLink database were eligible for inclusion. LV PCT stability was evaluated using ≥2 measurements over a 14-day period. Separately, a random sample of 7,250 patients with programmed right atrial and right ventricular amplitudes ≤2.5 V, LV thresholds ≤ 2.5 V, and LV pacing ≥90% were evaluated to estimate theoretical battery longevity improvement using LV safety margins of 0.5 and 1.5 V. Threshold stability analysis in 43,256 patients demonstrated LV PCT stability of <0.5 V in 77% of patients and <1 V in 95%. Device longevity analysis showed that the use of a 0.5-V safety margin increased average battery longevity by 0.62 years (95% confidence interval 0.61 to 0.63) compared with a safety margin of 1.5 V. Patients with LV PCTs >1 V had the greatest increases in battery life (mean increase 0.86 years, 95% confidence interval 0.85 to 0.87). In conclusion, nearly all CRT defibrillator patients had LV PCT stability <1.0 V. Decreasing the LV safety margin from 1.5 to 0.5 V provided consistent delivery of CRT for most patients and significantly improved battery longevity.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25933732      PMCID: PMC4480976          DOI: 10.1016/j.amjcard.2015.03.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  10 in total

1.  Cardiovascular implantable electronic device replacement infections and prevention: results from the REPLACE Registry.

Authors:  Daniel Z Uslan; Marye J Gleva; David K Warren; Theofanie Mela; Mina K Chung; Venkateshwar Gottipaty; Richard Borge; Dan Dan; Timothy Shinn; Kevin Mitchell; Richard G Holcomb; Jeanne E Poole
Journal:  Pacing Clin Electrophysiol       Date:  2011-11-11       Impact factor: 1.976

2.  Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry.

Authors:  Jeanne E Poole; Marye J Gleva; Theofanie Mela; Mina K Chung; Daniel Z Uslan; Richard Borge; Venkateshwar Gottipaty; Timothy Shinn; Dan Dan; Leon A Feldman; Hanscy Seide; Stuart A Winston; John J Gallagher; Jonathan J Langberg; Kevin Mitchell; Richard Holcomb
Journal:  Circulation       Date:  2010-10-04       Impact factor: 29.690

3.  Automated left ventricular capture management.

Authors:  George H Crossley; Hardwin Mead; Karen Kleckner; Todd Sheldon; Lynn Davenport; Manya R Harsch; Purvee Parikh; Brian Ramza; Robert Fishel; J Russell Bailey
Journal:  Pacing Clin Electrophysiol       Date:  2007-10       Impact factor: 1.976

4.  Automatic management of left ventricular stimulation: hints for technologic improvement.

Authors:  Mauro Biffi; Matteo Bertini; Davide Saporito; Matteo Ziacchi; Silvia Stabellini; Sergio Valsecchi; Valeria Ricci; Giuseppe Boriani
Journal:  Pacing Clin Electrophysiol       Date:  2009-03       Impact factor: 1.976

5.  Cost-effectiveness of implantable cardioverter-defibrillators.

Authors:  Gillian D Sanders; Mark A Hlatky; Douglas K Owens
Journal:  N Engl J Med       Date:  2005-10-06       Impact factor: 91.245

Review 6.  The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Authors:  M Fox; S Mealing; R Anderson; J Dean; K Stein; A Price; R S Taylor
Journal:  Health Technol Assess       Date:  2007-11       Impact factor: 4.014

7.  Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR.

Authors:  Daniel B Kramer; Kevin F Kennedy; John A Spertus; Sharon-Lise Normand; Peter A Noseworthy; Alfred E Buxton; Mark E Josephson; Peter J Zimetbaum; Susan L Mitchell; Matthew R Reynolds
Journal:  Heart Rhythm       Date:  2014-02       Impact factor: 6.343

8.  Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.

Authors:  Giuseppe Boriani; Frieder Braunschweig; Jean Claude Deharo; Francisco Leyva; Andrzej Lubinski; Carlo Lazzaro
Journal:  Europace       Date:  2013-05-21       Impact factor: 5.214

9.  Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients.

Authors:  Jens Brock Johansen; Ole Dan Jørgensen; Mogens Møller; Per Arnsbo; Peter Thomas Mortensen; Jens Cosedis Nielsen
Journal:  Eur Heart J       Date:  2011-01-20       Impact factor: 29.983

10.  Fluctuation of left ventricular thresholds and required safety margin for left ventricular pacing with cardiac resynchronization therapy.

Authors:  Haran Burri; Bart Gerritse; Lynn Davenport; Myriam Demas; Christian Sticherling
Journal:  Europace       Date:  2009-05-12       Impact factor: 5.214

  10 in total
  3 in total

1.  Impact of quadripolar LV leads on heart failure hospitalization rates among patients implanted with CRT-D: data from the Israeli ICD Registry.

Authors:  Eran Leshem; Mahmoud Suleiman; Avishag Laish-Farkash; Moti Haim; Michael Geist; David Luria; Michael Glikson; Ilan Goldenberg; Yoav Michowitz
Journal:  J Interv Card Electrophysiol       Date:  2017-12-23       Impact factor: 1.900

2.  Increased hs-CRP and decreased 1,25-dihydroxyvitamin D are associated with increased left ventricle lead threshold.

Authors:  Gökhan Gözübüyük; Mevlüt Koç; Onur Kaypaklı; Durmuş Yıldıray Şahin
Journal:  J Interv Card Electrophysiol       Date:  2016-05-28       Impact factor: 1.900

3.  Novel active fixation lead guided by electrical delay can improve response to cardiac resynchronization therapy in heart failure.

Authors:  Matteo Casale; Maurizio Mezzetti; Marianna Gigliotti De Fazio; Loredana Caccamo; Paolo Busacca; Giuseppe Dattilo
Journal:  ESC Heart Fail       Date:  2021-12-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.